| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Alvocidib | Alvocidib (Flavopiridol) Fluoro Analogue | VL5990002 | View CAS 1271744-68-3 |
Alvocidib Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Alvocidib | Alvocidib (Flavopiridol) Fluoro Analogue | VL5990002 | View CAS 1271744-68-3 |
[rfq_list]
| Catalogue No. | VL5990002 |
| CAS No. | 1271744-68-3 |
| Molecular Formula | C21H20FNO5 |
| Molecular Weight | 385.39 g/mol |
| Parent drug | Alvocidib |
| IUPAC Name | 2-(2-fluorophenyl)-5, 7-dihydroxy-8-((3S, 4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one |
| Synonyms | N/A |
| References | Zeidner, Joshua F., and Judith E. Karp. “Clinical Activity of Alvocidib (Flavopiridol) in Acute Myeloid Leukemia.” Leukemia Research, vol. 39, no. 12, Dec. 2015, pp. 1312–18, https://doi.org/10.1016/j.leukres.2015.10.010. |
| Status | In-stock |
| ListName | Alvocidib (Flavopiridol) Fluoro Analogue |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
